• Most Recent
  • Most Relevant
2 results
Pills and tables
Insight
Healthy returns: European life sciences M&A heats up as sector faces demographic reckoning
M&A Explorer | Dealmaking in Europe's life sciences sector has been relatively muted in recent years, but the first half of 2025 has shown signs of strength as companies respond to the stark realities of an aging population
medicines
Insight
Oncology dealmaking fuels biotech M&A
M&A Explorer | Growing demand for cancer drugs, along with patent expiries and AI innovation, are driving dealmaking in the red-hot oncology space